Canada markets closed

Acorda Therapeutics, Inc. (CDG.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
8.420.00 (0.00%)
At close: 03:32PM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-263,425
-252,854
-65,916
-103,954
-99,594
-
Depreciation & amortization
24,635
31,666
32,809
33,953
41,298
-
Deferred income taxes
-41,139
-43,177
30,669
-5,186
4,667
-
Stock based compensation
537
478
1,493
2,995
8,100
-
Change in working capital
-16,691
-10,831
1,698
24,935
-11,954
-
Accounts receivable
-10
-3,432
2,585
3,191
1,890
-
Inventory
-654
-3,403
5,796
7,860
-3,456
-
Accounts Payable
-4,700
884
-7,359
1,108
-8,971
-
Other working capital
-27,415
-14,248
-21,060
-41,539
-65,396
-
Other non-cash items
17,610
9,412
5,502
7,065
-25,953
-
Net cash provided by operating activites
-27,151
-13,984
-20,924
-41,348
-61,006
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-264
-136
-191
-4,390
-
Purchases of investments
-
-
-
-
0
-226,587
Sales/Maturities of investments
-
-
-
0
63,750
316,508
Net cash used for investing activites
-264
-264
-136
73,778
59,360
-
Cash flows from financing activities
Debt repayment
-
-
0
-69,655
-597
-55,813
Common stock issued
-
-
-
-
0
24
Common stock repurchased
-
-
-
-
0
-91
Other financing activites
-
-
-
-
-1,071
-4,670
Net cash used privided by (used for) financing activities
-
-
0
-69,655
-1,668
-60,550
Net change in cash
-27,417
-14,060
-20,548
-37,672
-2,296
-
Cash at beginning of period
37,754
44,675
65,223
102,895
105,191
-
Cash at end of period
10,339
30,615
44,675
65,223
102,895
-
Free Cash Flow
Operating Cash Flow
-27,151
-13,984
-20,924
-41,348
-61,006
-
Capital Expenditure
-
-264
-136
-191
-4,390
-
Free Cash Flow
-27,415
-14,248
-21,060
-41,539
-65,396
-